In order to further explore the correlation of GRHL2 expression with clinicopathological characteristics of acute leukemia patients, we divided the above 60 acute leukemia patients into the low-expression group of GRHL2 (above mean, n = 31) and the high-expression group of GRHL2 (below mean, n = 29) (Figure 1(b)). This evidence concerns the gene GRHL2 and acute leukemia.